← Back

Early biologics vs immunomodulators in jejunal CD

What is the evidence that early biologics improve long-term outcomes compared with conventional immunomodulators in patients with isolated jejunal CD

ContestedNot yet clinician-reviewed

What is known

  • A systematic review of UGICD (esophagus/stomach/duodenum/jejunum) found only observational data for anti-TNF, six studies, none RCTs, results heterogeneous. 1
  • In 39 adults with jejunal CD, infliximab gave higher 1-year segmental endoscopic and ulcer healing than ustekinumab, with vedolizumab lowest, a biologic-vs-biologic, not early-vs-immunomodulator, comparison. 1
  • Pediatric cohorts report durable clinical/endoscopic improvement with proximal disease but explicitly did not attribute long-term outcomes to specific regimens given retrospective design and evolving therapy. 2,3

What is unknown / caveats

  • No RCT and no direct early-biologic vs immunomodulator comparison in isolated jejunal CD
  • Jejunal disease pooled within broader UGICD; outcomes not isolated
  • Pediatric cohorts retrospective, small, confounded by evolving treatment strategies
  • The corpus contains no trial isolating early-biologic timing against immunomodulators for jejunal disease.

References

  1. Chatto M, Alaskar D, Ma C, Yuan Y, Vuyyuru SK, Bessissow T, Narula N, Danese S, Peyrin-Biroulet L, Singh S, Jairath V, Sedano R. Pharmacological management of upper gastrointestinal Crohn's disease: a systematic review. J Crohns Colitis. 2025. PMID: 41148060.
  1. Jaakkola T, Merras-Salmio L, Nikkonen A, Kolho KL. Long-term follow-up of children with Crohn's disease and small bowel mucosal lesions detected through video capsule endoscopy. J Pediatr Gastroenterol Nutr. 2025. PMID: 39487088.
  1. Facanali MR, Graciolli Facanali CB, Borba MR, Sobrado CW, Safatle-Ribeiro AV. Baseline Double-Balloon Enteroscopy Findings and Long-Term Outcomes in Pediatric Crohn's Disease. Cureus. 2026. PMID: 41853420.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.


Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.

Reviewer notes

answered 2026-08-04 · corpus build b71369a6 · faithfulness 0.9333333333333333